The Valley Desk

NCT01472939 · Interventional trial

Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)

Overall registry status Completed

Phase 2

Conditions Gastroesophageal Reflux Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov